Search
Searching Content indexed under Life Sciences, Biotechnology & Nanotechnology by Norton Rose Fulbright Canada LLP ordered by Published Date Descending.
Links to Result pages
 
1 2 3 4 5 6 7 8 9 10 11 . . .  
>>Next
 
Title
Country
Organisation
Author
Date
1
Competition Bureau Issues Statement Regarding Off-Label Use Of Vaccines
The Competition Bureau recently conducted a preliminary investigation into possible competition concerns arising from a proposal to include a clause in a procurement contract that would restrict off-label use of a vaccine.
Canada
31 Jul 2019
2
Après un second coup d'œil, la CAF confirme le rejet de demande en contrefaçon dans un litige portant sur des dispositifs médicaux ophtalmiques
Dans TearLab Corporation c. I-MED Pharma Inc, 2019 FCA 179, la Cour d'Appel Fédérale (CAF) a confirmé le rejet de l'action en contrefaçon de brevet de TearLab contre I-MED.
Canada
19 Jul 2019
3
Federal Court Of Appeal Agrees That The PMPRB Incorrectly Applied The Patent-Pertaining Analysis
The Federal Court of Appeal has provided new guidance on the proper approach to the "patent pertaining" analysis used by the Patented Medicine Prices Review Board, including on the identification of the medicine ...
Canada
11 Jul 2019
4
CUSMA Implementation Bill Introduced
CUSMA provides more protections for biologic and innovative pharmaceuticals under Canadian law.
Canada
10 Jun 2019
5
Impact Of Trade-Marks Act Amendments On Pharmaceutical Brand Owners
The amendments to Canada's Trade-marks Act taking effect on June 17, 2019, will present a number of advantages to the pharmaceutical industry, but will also raise key issues for consideration for brand owners.
Canada
27 May 2019
6
La santé à l'ère numérique : opportunités et écueils
Notre groupe organise une conférence bien spéciale le 22 mai prochain sur les conséquences de l'intersection entre la santé et l'intelligence artificielle
Canada
21 May 2019
7
Federal Court Of Appeal Affirms Cancellation Of Reconsideration Of ANDS For Apo-Omeprazole
The Federal Court dismissed Apotex's application for judicial review of the Minister's decision to cancel the reconsideration process.
Canada
7 May 2019
8
Building The Health Systems Of Tomorrow: Dealmaking And The Future Of The Life Sciences Sector
A major recurrent theme is the ongoing transformation of the industry.
Canada
25 Apr 2019
10
FCA Confirms Entirety Of Inventors' Conduct Is Relevant In Obviousness Analysis And Upholds Inventiveness Of Crystal Form Patent
The Federal Court of Appeal upheld the validity of Canadian Patent 2,436,668 which covers Form I ODV succinate (marketed as PRISTIQ) in two separate appeals by Apotex Inc. and Teva Canada Ltd, finding that the claims were novel and inventive.
Canada
21 Feb 2019
11
Top Headlines Of 2018
Last year ushered in a number of changes to the Canadian pharmaceutical and life sciences sector.
Canada
18 Jan 2019
12
Disruptive Technology As A Driver Of M&A In The Life Sciences And Healthcare Sector – Key Trends
The convergence of technology and life sciences was a defining feature of 2018.
Canada
10 Jan 2019
13
Bill C-86 Receives Royal Assent, Bringing Amendments Across Canada's IP Statutes
The patent-law changes in Bill C-86 are not specifically directed at pharmaceutical patentees, but have the potential to affect this area of litigation.
Canada
19 Dec 2018
14
What Is The Impact Of The USMCA On IP In Canada?
The US-Mexico-Canada Agreement (USMCA), which is set to replace NAFTA, concluded on September 30, 2018.
Canada
26 Nov 2018
16
Ontario Superior Court Rejects Apotex Attempts To Revive The Promise Doctrine By Dismissing Motion For Leave To Amend, Awards Substantial Indemnity Costs
The Ontario Superior Court of Justice (ONSC) recently denied Apotex's attempt to repackage the now defunct "promise of the patent" doctrine (the Promise Doctrine).
Canada
22 Nov 2018
17
File-Wrapper Admissibility And Other Changes To The Patent Act Are Coming: What's New For Pharmaceutical Patentees In Bill C-86
The federal government's recent omnibus budget bill, Bill C-86 tabled October 29th, 2018, proposes significant changes to Canada's IP laws.
Canada
8 Nov 2018
18
The Impact Of The GDPR On Clinical Trial Research
In April 2016, the European Parliament adopted the General Data Protection Regulation (GDPR) to modernize its data protection legislation.
Canada
31 Oct 2018
19
New Protections For Biologics And Other Pharmaceuticals Under The United States-Mexico-Canada Agreement (USMCA)
As we reported, Canada has joined a new trilateral trade deal called the United States-Mexico-Canada Agreement (USMCA).
Canada
16 Oct 2018
Links to Result pages
 
1 2 3 4 5 6 7 8 9 10 11 . . .  
>>Next